Related content

Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect

By Garg Madhu   Ackland Stephen  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 963-966

Springer Publishing Company

Access to resources Recommend Favorite

Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats

By Orhan Bulent   Yalcin Suayib   Nurlu Gulay   Zeybek Dilara   Muftuoglu Sevda  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 197-203

Humana Press, Inc

Access to resources Recommend Favorite

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

By Kono Toru   Hata Taishi   Morita Satoshi   Munemoto Yoshinori   Matsui Takanori   Kojima Hiroshi   Takemoto Hiroyoshi   Fukunaga Mutsumi   Nagata Naoki   Shimada Mitsuo   Sakamoto Junichi   Mishima Hideyuki  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1283-1290

Springer Publishing Company

Access to resources Recommend Favorite

Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity

By Cavaletti G.   Zanna C.  

European Journal of Cancer, Vol. 38, Iss. 14, 2002-09 ,pp. : 1832-1837

Elsevier

Access to resources Recommend Favorite

A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity

By Kobrinsky B.   Joseph S.   Muggia F.   Liebes L.   Beric A.   Malankar A.   Ivy P.   Hochster H.  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1073-1078

Springer Publishing Company

Access to resources Recommend Favorite